Intended for healthcare professionals

News

Alzheimer’s disease: FDA approves lecanemab amid cost and safety concerns

BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p73 (Published 11 January 2023) Cite this as: BMJ 2023;380:p73